Merck & Co., Inc. (NYSE:MRK) ranks among the best magic formula stocks to invest in. On July 10, UBS reiterated its Buy ...

Merck & Company, Inc. (NYSE:MRK) is one of the high-margin pharma stocks to buy now. Jefferies has raised its price target on ...

Pharmaceutical Technology serves as the connection to bio manufacturing and development, featuring regulatory updates and ...

On July 9, Merck announced that it would acquire Verona Pharma, a U.K.-based biotechnology company specializing in the ...

The Strategy underperformed its benchmark as detractors in the consumer discretionary and communication services sector ...

Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or ...

Every so often, activist investors swarm around underperforming companies in a certain industry and pressure them to change strategy. Right now, it’s biotech startups that are flush with cash but ...

RBC Capital analyst Paul Treiber maintained a Hold rating on Open Text on July 22 and set a price target of $30.00. The company’s shares closed yesterday at $30.22. Take advantage of TipRanks Premium ...

Freshfields’ senior partner, Georgia Dawson, has been elected to serve a second term as senior partner alongside a ...

Wells Fargo analyst Mohit Bansal maintained a Hold rating on Merck & Company yesterday and set a price target of $97.00. The company’s shares closed yesterday at $81.52. Elevate ...

Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations ...

Merck & Co. faces headwinds despite being labeled an undervalued stock. Morgan Stanley recently lowered its price target to ...